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Background: We tested whether fatty liver, brachial-ankle pulse wave velocity (baPWV) and conventional
cardiovascular risk factors were associated with a coronary artery calcium (CAC) score > 0 (as a marker of the
presence of early atherosclerosis) in a cohort of healthy Korean adults.
Method: The study population consisted of individuals who underwent a comprehensive health examination in
2010 at Kangbuk Samsung Hospital, College of Medicine, Sungkyunkwan University in South Korea. The 6009
subjects of total 7371 participants who had an assigned CAC score following coronary computed tomography (CT)
scanning and baPWV were analyzed.
Results: Among the study subjects, 39.2% of the population had evidence of fatty liver by ultrasound and 4.6% of
the population had evidence of CAC score > 0. Among individuals with a CAC score = 0, 38% of the individuals had
fatty liver compared with 58% of the individuals with a CAC score > 0. The individuals with a CAC score > 0 also
had higher blood pressure and had more metabolic abnormalities. The prevalence of CAC score > 0 was increased
according to baPWV quartiles and was higher in the fatty liver group in comparison with those without fatty liver.
The odds ratio for CAC score > 0, after adjusting for clinical risk factors, showed a significant elevation with
increasing quartiles of baPWV and the presence of fatty liver.
Conclusion: We showed that both fatty liver and baPWV are independently associated with the presence of CAC, a
marker of preclinical atherosclerosis. These associations are independent of conventional risk factors and medical history.
Keywords: baPWV, Arterial stiffness, Coronary artery calcium (CAC) score, Atherosclerosis, Fatty liverIntroduction
Arterial stiffness has been shown to be an independent
predictor of cardiovascular mortality and a marker of
early detection of target organ damage by cardiovascular
disease [1,2]. Pulse wave velocity (PWV) is a practical
marker of arterial stiffness; brachial-ankle (ba) PWV has
been widely used in clinical research in Korea and Japan
[3-6]. baPWV is a relatively simple, noninvasive test that
could be a useful adjunct to conventional coronary ar-
tery disease (CAD) risk factors in identifying patients* Correspondence: kcmd.sung@samsung.com
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stated.and subgroups in the population at increased risk for
cardiovascular events. Although arterial stiffness and
CAD are closely related, the correlation between arterial
stiffness and coronary artery calcium (CAC) score, an
early marker of atherosclerosis, in the general population
has not yet been studied [7-10].
Several prospective studies have reported an increased
incidence of cardiovascular events in people with nonal-
coholic fatty liver disease (NAFLD) [11-14]. However, it
is still unclear whether NAFLD is simply a risk marker
that is coexistant with other recognized cardiovascular
disease (CVD) risk factors associated with insulin resist-
ance or whether it is an independent cardiovascular risk
factor on its own [15,16]. Fatty liver has been shown to
be associated with CAC score [17]. CAC scoring withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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method to demonstrate the presence of early athero-
sclerosis, and the use of CAC score may improve the
prediction of cardiovascular (CV) risk in asymptomatic
and high risk individuals [7,8,18-20].
Thus, analyzing the association between CAC score
with NAFLD and arterial stiffness may provide insight
into a better understanding of the relationship between
NAFLD, arterial stiffness and atherosclerosis. Using the
data from a retrospective cohort study with measure-
ments of fatty liver, baPWV and CAC score together
with conventional cardiovascular risk factors, we investi-
gated the relationship between fatty liver, baPWV and a
CAC score > 0. Thus, we tested whether fatty liver,
baPWV and conventional risk factors of metabolic syn-
drome (MetS) (waist circumference, glucose, triglyceride,
high density lipoprotein cholesterol [HDL-C], and blood
pressure) were associated with a CAC score > 0 (as a
marker of the presence of early atherosclerosis) in a
population cohort in Korea.
Methods
The study population consisted of individuals who
underwent a comprehensive health examination in 2010
at Kangbuk Samsung Hospital, College of Medicine,
Sungkyunkwan University in South Korea. The popula-
tion included 7,371 participants who had an assigned
CAC score following coronary CT scanning and PWV.
The individuals were excluded from the current analyses
if data were missing for the following variables: alcohol
consumption (n = 38), smoking (n = 46), exercise (n = 37)
and waist circumference (n = 7). Furthermore, to investi-
gate healthy subjects without the influence of past med-
ical history and medication, we excluded those who
answered prior cerebrovascular accidents (n = 16), prior
CAD (n = 62), prior diabetes (n = 254), prior hypertension
(n = 835) and prior hepatitis or positive hepatitis B/C viral
serologic marker (n = 269), leaving data of 6,009 partici-
pants for this analysis. The study was approved by the
institutional review board at Kangbuk Samsung Hospital.
Informed consent requirement was waived because per-
sonal identifying information was not accessed.
BMI was calculated as weight in kilograms divided by
height in meters squared. Blood samples for laboratory ex-
aminations were collected after an overnight fast. Fasting
plasma glucose, total cholesterol, triglyceride (TG) and
HDL-C concentrations were measured using Bayer Re-
agent Packs on an automated chemistry analyzer (Advia
1650 Autoanalyzer; Bayer Diagnostics, Leverkusen,
Germany). Low density lipoprotein cholesterol (LDL-C)
concentration was calculated using direct measurement.
Questionnaires were used to ascertain information
regarding alcohol consumption (glass/day), smoking
(never, ex, current), and frequency of moderate activityper week. Moderate activity was defined as more than
30 minute of activity per day that induced slight
breathlessness.
All computed tomography scans were obtained with
a Lightspeed VCT XTe-64 slice MDCT scanner (GE
Healthcare, Tokyo, Japan) with the same standard
scanning protocol using 40*2.5-mm section colli-
mation, 400 ms rotation time, 120 kV tube voltage,
and 124 mAS (310 mA*0.4 second) tube current
under ECG-gated dose modulation. Quantitative CAC
scores were calculated according to the method de-
scribed by Agatston et al. [14].
Bilateral brachial and ankle blood pressure, and arter-
ial pulse waves were measured using an automatic wave
analyzer VP-1000 (Omron Healthcare Co., Ltd, Kyoto,
Japan). Individuals were examined in the supine position
after at least 5 minute of bed rest. Bilateral brachial and
posterior tibial artery pressure waveforms were recorded
by an oscillometric method using the occlusion/sensing
cuffs adapted to both arms and both ankles. baPWV was
calculated for each arterial segment as the path length
divided by the corresponding time interval. The coeffi-
cient of variation was 6.5% for baPWV.
Abdominal ultrasonography (Logic Q700 MR; GE,
Milwaukee,WI, USA) using a 3.5 MHz probe was per-
formed in all subjects by experienced clinical radiolo-
gists, and fatty liver was diagnosed, based on standard
criteria, including hepatorenal echo contrast, liver
brightness, and vascular blurring [21].
Statistical analysis
Statistical analysis of the data was performed using SPSS
version 15.0 (SPSS, Point Richmond, CA, USA). Con-
tinuous variables were expressed as mean ± SD for nor-
mally distributed variables or median (interquartile
range) for other variables. baPWV was stratified into
quartiles. Categorical variables were expressed as per-
centages and compared between groups using the χ2
test. Logistic regression was used to determine the odds
ratio (OR) and 95% confidence intervals (CI) for the
presence of a CAC score > 0 for the highest baPWV
quartile compared with the lowest baPWV quartile as
the reference. In these regression models, the following
variables were entered to investigate the independence
of the relationship between baPWV in the highest quar-
tile and CAC scores: age, sex, smoking status (never/ ex
or current), frequency of moderate activity per week (de-
fined by ≥ 3 episodes of moderate activity of > 30 minute
per day that induced slight breathlessness), LDL-C, TG,
HDL-C, alcohol consumption (glass/day), waist circum-
ference and fatty liver. We used logistic regression to de-
termine the OR for the presence of a CAC score > 0 in
individuals stratified by quartiles of baPWV and as a
function of fatty liver.
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As shown in Table 1, all baseline characteristics except
fasting blood glucose level were significantly different
between individuals with a CAC score = 0 compared
with those with a CAC score > 0. Among the study sub-
jects, 39.5% of them had evidence of fatty liver by ultra-
sound and 4.5% had evidence of a CAC score > 0.
Among individuals with a CAC score =0, 38.6% of the
individuals had fatty liver compared with 59.0% in the
individuals with a CAC score > 0. The individuals with a
CAC score > 0 also had higher blood pressure and had
more metabolic abnormalities including higher TG and
LDL-C concentrations and lower HDL-C concentration.
The prevalence of CAC score > 0 was increased according
to baPWV quartiles and was higher in the fatty liver group
compared with those with no fatty liver (Figure 1).
In the multiple regression model adjusted for multiple
cardiovascular risk factors, we investigated the OR for
CAC score > 0 with increasing quartiles of baPWV con-
trolled for the presence of fatty liver. Table 2 shows the
OR for CAC score > 0, after adjustment for age, sex, glu-
cose, TG, HDL-C, LDL-C, waist circumference, systolicTable 1 Baseline characteristics according to CAC score = 0 an
CAC = 0
Subjects number 5736




Fasting glucose (mg/dl) 94.7 ± 11.0
Triglyceride (mg/dl) 135.4 ± 92.6
Median[interquartile] 113 [79,163]
HDL- cholesterol (mg/dl) 52.9 ± 12.4
LDL- cholesterol (mg/dl) 123.9 ± 31.9
ALT (U/L) 27.3 ± 32.8
AST (U/L) 24.0 ± 17.0
BMI (kg/m2) 24.1 ± 3.0
Waist circumference (cm) 83.9 ± 8.1
Systolic BP (mmHg) 116.3 ± 12.0
Diastolic BP (mmHg) 74.4 ± 8.6
HR (beats/min) 64.5 ± 8.9
Mean baPWV (cm/s) 1302.9 ± 146.3
Alcohol (glass/d) 1.6 ± 2.5
Current smoker, n (%) 1254 (21.9%)
Physical activity (≥ 3/week), n (%) 1003 (17.5%)
Fatty liver, n (%) 2215 (38.6%)
Data are mean±SD or median (interquartile range) unless otherwise noted.
CAC = coronary artery calcium; HDL = high-density lipoprotein; LDL = low-density li
BMI = body mass index; BP = blood pressure; HR = heart rate; baPWV = brachial ank
Physical activity category defined by ≥ 3 episode of moderate activity of > 30 min/blood pressure, alcohol consumption, smoking status,
physical activity and fatty liver; the results showed a sig-
nificantly increased in the highest quartile of baPWV.
Next, we examined the prevalence (%) and adjusted
OR of CAC score > 0 according to the presence of fatty
liver, stratified by quartiles of baPWV (Table 3). In the
lowest PWV quartile, there were 15 (1.4%) subjects with
a CAC score > 0 were noted in 1084 subjects with no
fatty liver compared to 20 (4.7%) of 422 subjects with a
CAC score > 0 in the group with fatty liver (p < 0.001).
In the group (of people in the baPWV 1st quartile) with
fatty liver compared with the group with no fatty liver,
the adjusted OR (95% CI, p value) for CAC score > 0
was 1.86 (0.81 – 4.30, p = 0.145) (Model 4). However, in
the 2nd quartile there were 20 (2.2%) subjects with a
CAC score > 0 in 921 subjects with no fatty liver, com-
pared to 32 (5.4%) of 592 subjects with fatty liver (p <
0.001). The adjusted OR for CAC score > 0 was 2.80
(1.42 – 5.55, p = 0.003). In the highest baPWV quartile,
even after adjusting for many kinds of variables (model
4) in healthy subjects, we identified a statistically signifi-
cant increased OR, 1.90 (1.19 – 3.03, p = 0.007).d CAC score >0
CAC > 0 p
273




95.0 ± 19.0 0.700
151.6 ± 100.8 0.005
130 [94,181]
49.0 ± 11.0 < 0.001
137.8 ± 29.3 < 0.001
29.6 ± 19.5 < 0.001
26.5 ± 16.3 < 0.001
24.8 ± 2.6 < 0.001
85.8 ± 6.8 < 0.001
119.1 ± 12.1 < 0.001
76.6 ± 8.1 < 0.001
66.4 ± 9.0 < 0.001
1379.9 ± 174.8 < 0.001




poproteinl; AST = Aspartate Aminotransferase; ALT = Alanine Aminotransferase;
le plse wave velocity.
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no fatty liver fatty liver
coronary artery calcium score>0
coronary artery
calcium score>0
Figure 1 The prevalence of CAC score > 0 2.4% in baPWV Quartile 1 (Q1), 3.4% in 2 (Q2), 4.6% in 3 (Q3), 7.9% in 4 (Q4) (p < 0.001)
and 3.1% in no fatty liver group, 6.7% in fatty liver group. (p < 0.001).
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higher levels of CAC score showed similar point esti-
mates, but wider confidence intervals, as a consequence
of there being only 147 people with CAC score > 20 and
40 people with CAC score > 100. After adjusting the
same variables in Table 2, the OR for CAC score > 20 in
the 2nd quartile of baPWV is 1.43 (0.35 - 5.88, p = 0.35);
in the 3rd quartile, 1.55 (0.38 - 6.29, p = 0.54); in the 4th
quartile, 3.98 (1.08 - 14.6 p = 0.38); and the OR for fatty
liver is 1.98 (0.94 - 4.16, p = 0.07). For CAC score > 100,
the 2nd quartile of baPWV is 0.91 (0.49 - 1.71, p = 0.77);
in the 3rd quartile, 0.99 (0.54 - 1.82, p = 0.90), in the 4thTable 2 Associations between baPWV quartiles, fatty
liver, cardio-metabolic risk factors, and CAC score > 0; de-
rived from a multivariable logistic regression model con-
taining all variables
Odds ratio (95% CI) p
Sex, female 0.309 (0.177-0.539) < 0.001
Age, per year 1.140 (1.119-1.162) < 0.001
Triglyceride, per mg/dl 0.999 (0.997-1.001) 0.367
HDL cholesterol, per mg/dl 0.979 (0.965-0.992) 0.002
LDL cholesterol, per mg/dl 1.009 (1.005-1.013) < 0.001
Glucose, per mg/dl 0.985 (0.973-0.998) 0.021
Systolic BP, per mmHg 1.005 (0.992-1.017) 0.476
Alcohol, glass/d 1.035 (0.993-1.079) 0.104
Smoking (no versus ex or current) 0.958 (0.725-1.267) 0.765
Physical activity ≥ 3/week 1.315 (0.957-1.807) 0.091
Waist circumference per cm 0.983 (0.962-1.006) 0.145
Fatty liver 1.953 (1.450-2.632) < 0.001
baPWV Quartile 1
Quartile 2 1.014 (0.646-1.591) 0.952
Quartile 3 1.143 (0.736-1.774) 0.551
Quartile 4 1.627 (1.005-2.507) 0.027
CAC score = coronary artery calcium score; HDL = high-density lipoprotein;
LDL = low-density lipoprotein; BP = blood pressure; baPWV = brachial ankle
pulse wave velocity.quartile, 1.62 (0.90 - 2.91, p = 0.11); and the OR for fatty
liver is 1.36 (0.92 - 2.01, p = 0.13). By adopting higher
thresholds, there is decreased power to show the inde-
pendent associations with baPWV or fatty liver with the
CAC score, because there are fewer people with a CAC
score > 20 or >100 compared to people with a CAC
score > 0. However, it is important to note that (with
wide 95% CIs) the B coefficients are very similar in the
relationships between fatty liver or baPWV with the
CAC score, regardless of whether the threshold is CAC
> 0 or CAC score > 20. Thus, these data suggest that the
strengths of the relationships between both fatty liver
and baPWV with the CAC score are similar, regardless
of the threshold of CAC score chosen for the analyses.
Discussion
We demonstrated here for the first time that both fatty
liver and baPWV are associated with a CAC score > 0,
independently of each other and of MetS components in
a healthy Korean occupational cohort. More importantly,
these results also showed that the combination of fatty
liver and baPWV is associated with an increased preva-
lence of CAC score > 0 (1.4% in the lowest baPWV quar-
tile with no fatty liver versus 9.8% in the highest PWV
quartile with fatty liver). These results were obtained
from the retrospective analysis of the data from a
healthy (no prior medical history), young, occupational
cohort, and the association between both fatty liver and
baPWV as a continuous variable (or baPWV as a cat-
egorical variable) and CAC score > 0 persisted after ad-
justment for the features of MetS and life style.
To date, there are no similar studies investigating the
relationships between a marker of early development of
coronary artery atherosclerosis and fatty liver, baPWV
and MetS features in a large, predominantly healthy,
middle-aged cohort, even though some previous studies
have shown associations between increased baPWV and
the presence of coronary artery disease [22] or between
liver fat, measured by ultrasound or CT, and CAC




Number (%) Odds ratio (95% CI), p
No fatty liver Fatty liver Model 1 Model 2 Model 3 Model 4
Q1 < 1209 cm/s 15/1084 (1.4%) 20/422 (4.7%) 2.44 (1.21 - 4.90), 0.013 2.62 (1.26 - 5.44), 0.010 2.06 (0.92 - 4.62), 0.080 1.86 (0.81 - 4.30), 0.145
1209 cm/s ≤ Q2
< 1301 cm/s
20/921 (2.2%) 32/592 (5.4%) 2.15 (1.20 - 3.85), 0.010 2.25 (1.25 - 4.05), 0.007 2.26 (1.20 - 4.25), 0.012 2.80 (1.42 - 5.55), 0.003
1301 cm/s≤ Q3
<1394 cm/s
29/843 (3.4%) 39/651 (6.0%) 1.61 (0.97 - 2.68), 0.068 1.66 (0.99 - 2.78), 0.055 1.73 (1.00 - 3.02), 0.052 1.85 (1.03 - 3.34), 0.040
Q4 ≥ 1394 cm/s 48/785 (6.1%) 70/711 (9.8%) 2.04 (1.35 - 3.08), 0.001 2.04 (1.34 - 3.110), 0.001 1.74 (1.12 - 2.71), 0.015 1.90 (1.19 - 3.03), 0.007
baPWV = brachial ankle pulse wave velocity.
Model 1: adjusted for age and sex.
Model 2: model 1 + adjusted for alcohol, smoking status, physical activity, systolic blood pressure.
Model 3: model 2 + adjusted for glucose, Triglyceride, HDL cholesterole and LDL cholesterol.
Model 4: model 3 + adjusted for waist circumference.
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tiple complex metabolic and proinflammatory changes
that have an effect on the vasculature [15] indicate that
it is very difficult to identify causality from the relation-
ship between NAFLD, PWV and CVD.
baPWV reflects the stiffness of both the central and
peripheral muscular arteries and serves as a simple index
of the severity of arterial stiffness and atherosclerosis
[26]. Measurement of baPWV is a non-invasive and in-
expensive procedure in clinical practice. To date, several
studies have shown that PWV measurements obtained
by non-invasive automatic devices do not only indicate
vascular damage but also predict damage [27]. PWV has
been associated with known cardiovascular risk factors,
such as age, hypertension and diabetes mellitus [28-30].
A recently developed instrument, which measures
baPWV using a volume-rendering method, has been
widely used in clinical research, especially in East Asian
countries during the past 10 years. PWV has also been
associated with the presence and quantity of coronary
artery calcium [31,32]. In this study, a receiver operating
characteristic (ROC) curve was employed to define a
cutoff value of baPWV that could discriminate between
patients with and without a CAC score > 0, but the area
under the curve was only 0.63, indicating that was nearly
linear. For this reason, we believe that using a cut point
to find CAC score > 0 would not be helpful in clinical
practice. In the results, the prevalence of higher physical
activity is significantly higher in the CAC > 0 group (p =
0.011). This is an unexpected finding and therefore is
difficult to explain. In this cohort, information about
lifetime physical activity energy expenditure is not avail-
able. We only had basic self-reported information on
physical activity levels in this cohort and consequently it
is likely that estimates are highly likely to be subject to
measurement error and there is scope for residual
confounding.
There are a few limitations to our study. Fatty liver
was assessed by liver ultrasound, and ultrasonographyhas limited sensitivity, being unable to detect liver fat in-
filtration below 30% by liver weight. Ultrasonography
was performed by experienced clinical radiologists who
also diagnosed fatty liver based on the known standard
clinical criteria that included hepatorenal echo contrast,
liver brightness, and vascular blurring. We are therefore
unable to include evidence of agreement between radiol-
ogists. However, in the presented analyses, we used the
clinical definition of fatty liver as a dichotomous expos-
ure variable. It is unlikely that fatty liver status was influ-
enced by CAC score, and consequently, any random
misclassification bias of fatty liver status would bias our
findings (showing the association between fatty liver and
CAC score > 0) toward null. Second, we used baPWV as
a measurement of arterial stiffness, although it is not the
gold standard method used to evaluate arterial stiffness.
However, several studies have reported that baPWV has
similar characteristics to carotid- femoral PWV, and
thus, is widely used especially in East Asian countries
[33,34]. Additionally, our study is limited to one ethnic
group, and the distribution of risk factors and the associ-
ation between NAFLD and CAC may differ by ethnic
group.
In conclusion, we showed that both fatty liver and
baPWV are independently associated with the presence
of CAC, a marker of preclinical atherosclerosis. These
associations are independent of conventional cardiovas-
cular risk factors, and after exclusion of prior medical
history.Abbreviations
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